Eugenics Revisited: Author Asks if We're Ready for Genetically Modified Humans
By Howard Lovy,
Foreword Reviews
| 03. 24. 2016
Untitled Document
If you think the argument over the benefits and risks of genetically modified foods is confusing and contentious, just wait until the debate over genetically modified people gets into full swing. All the elements are there: the potential to do great good through the eradication of disease and great harm through accidental or weaponized genetic destruction, not to mention the morally gray areas of so-called “designer babies” and corporate control over life-enhancing technologies.
The technology is almost here, and thinking ahead for us are authors like Paul Knoepfler, whose book GMO Sapiens: The Life-Changing Science of Designer Babies, an INDIEFAB finalist, tackles these tough issues and more. I was curious about what to expect from the next contentious public debate over science. So, I asked him.
Eugenics is forever associated with the ugly stain of Nazism and the forced sterilization of thousands in the United States. How can the idea of genetic modification of humans ever come back from that?
In researching and writing my book, I came across a wide range of opinions about human genetic...
Related Articles
By Roxanne Khamsi, The Atlantic | 07.07.2026
When Ludivine Verboogen and Romain Alderweireldt’s third child was born in Belgium in late 2015, they marveled at his long fingers. Perhaps one day he will be a famous pianist, they thought. But soon Ludivine grew worried that her son...
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Shayna Korol, Vox | 06.12.2026
AI company CEOs Sam Altman (OpenAI), Demis Hassabis (Google DeepMind), and Dario Amodei (Anthropic) disagree on a lot, like how fast the technology should develop, the best way to regulate it, and how to prepare society for smarter-than-human AI, among...